Yüklüyor......
QbD Based Media Development for the Production of Fab Fragments in E. coli
Ranibizumab is a biotherapeutic Fab fragment used for the treatment of age-related macular degeneration and macular oedema. It is currently expressed in the gram-negative bacterium, Escherichia coli. However, low expression levels result in a high manufacturing cost. The protein expression can be in...
Kaydedildi:
| Yayımlandı: | Bioengineering (Basel) |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6631317/ https://ncbi.nlm.nih.gov/pubmed/30925730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/bioengineering6020029 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|